Global and China Biosimilar Testing and Development Services Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Effector Binding
  • 1.2.3 ELISA
  • 1.2.4 Kinetic Binding Assays
  • 1.2.5 ADCC & CDC Cell-Based Assays
• 1.3 Market by Application
  • 1.3.1 Global Biosimilar Testing and Development Services Market Share by Application: 2020 VS 2026
  • 1.3.2 PK assay
  • 1.3.3 Tiered Immunogenicity testing
  • 1.3.4 NAb assays
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Biosimilar Testing and Development Services Market Perspective (2015-2026)
• 2.2 Global Biosimilar Testing and Development Services Growth Trends by Regions
  • 2.2.1 Biosimilar Testing and Development Services Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biosimilar Testing and Development Services Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Biosimilar Testing and Development Services Players by Market Size
  • 3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2015-2020)
  • 3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2015-2020)
• 3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
• 3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
  • 3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2019
• 3.5 Key Players Biosimilar Testing and Development Services Area Served
• 3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
• 3.7 Date of Enter into Biosimilar Testing and Development Services Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar Testing and Development Services Breakdown Data by Type (2015-2026)

• 4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2015-2020)
• 4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2021-2026)

5 Biosimilar Testing and Development Services Breakdown Data by Application (2015-2026)

• 5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2015-2020)
• 5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biosimilar Testing and Development Services Market Size (2015-2026)
• 6.2 North America Biosimilar Testing and Development Services Market Size by Type (2015-2020)
• 6.3 North America Biosimilar Testing and Development Services Market Size by Application (2015-2020)
• 6.4 North America Biosimilar Testing and Development Services Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Biosimilar Testing and Development Services Market Size (2015-2026)
• 7.2 Europe Biosimilar Testing and Development Services Market Size by Type (2015-2020)
• 7.3 Europe Biosimilar Testing and Development Services Market Size by Application (2015-2020)
• 7.4 Europe Biosimilar Testing and Development Services Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Biosimilar Testing and Development Services Market Size (2015-2026)
• 8.2 China Biosimilar Testing and Development Services Market Size by Type (2015-2020)
• 8.3 China Biosimilar Testing and Development Services Market Size by Application (2015-2020)
• 8.4 China Biosimilar Testing and Development Services Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Biosimilar Testing and Development Services Market Size (2015-2026)
• 9.2 Japan Biosimilar Testing and Development Services Market Size by Type (2015-2020)
• 9.3 Japan Biosimilar Testing and Development Services Market Size by Application (2015-2020)
• 9.4 Japan Biosimilar Testing and Development Services Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Biosimilar Testing and Development Services Market Size (2015-2026)
• 10.2 Southeast Asia Biosimilar Testing and Development Services Market Size by Type (2015-2020)
• 10.3 Southeast Asia Biosimilar Testing and Development Services Market Size by Application (2015-2020)
• 10.4 Southeast Asia Biosimilar Testing and Development Services Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Eurofins Scientific
  • 11.1.1 Eurofins Scientific Company Details
  • 11.1.2 Eurofins Scientific Business Overview
  • 11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
  • 11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2015-2020))
  • 11.1.5 Eurofins Scientific Recent Development
• 11.2 SGS
  • 11.2.1 SGS Company Details
  • 11.2.2 SGS Business Overview
  • 11.2.3 SGS Biosimilar Testing and Development Services Introduction
  • 11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2015-2020)
  • 11.2.5 SGS Recent Development
• 11.3 Charles River Laboratories
  • 11.3.1 Charles River Laboratories Company Details
  • 11.3.2 Charles River Laboratories Business Overview
  • 11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
  • 11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2015-2020)
  • 11.3.5 Charles River Laboratories Recent Development
• 11.4 Pharmaceutical Product Development
  • 11.4.1 Pharmaceutical Product Development Company Details
  • 11.4.2 Pharmaceutical Product Development Business Overview
  • 11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
  • 11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2015-2020)
  • 11.4.5 Pharmaceutical Product Development Recent Development
• 11.5 Exova
  • 11.5.1 Exova Company Details
  • 11.5.2 Exova Business Overview
  • 11.5.3 Exova Biosimilar Testing and Development Services Introduction
  • 11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2015-2020)
  • 11.5.5 Exova Recent Development
• 11.6 Source BioScience
  • 11.6.1 Source BioScience Company Details
  • 11.6.2 Source BioScience Business Overview
  • 11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
  • 11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2015-2020)
  • 11.6.5 Source BioScience Recent Development
• 11.7 Intertek Group
  • 11.7.1 Intertek Group Company Details
  • 11.7.2 Intertek Group Business Overview
  • 11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
  • 11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2015-2020)
  • 11.7.5 Intertek Group Recent Development
• 11.8 Medistri
  • 11.8.1 Medistri Company Details
  • 11.8.2 Medistri Business Overview
  • 11.8.3 Medistri Biosimilar Testing and Development Services Introduction
  • 11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2015-2020)
  • 11.8.5 Medistri Recent Development
• 11.9 Pace Analytical Services
  • 11.9.1 Pace Analytical Services Company Details
  • 11.9.2 Pace Analytical Services Business Overview
  • 11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
  • 11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2015-2020)
  • 11.9.5 Pace Analytical Services Recent Development
• 11.10 Sigma-Aldrich
  • 11.10.1 Sigma-Aldrich Company Details
  • 11.10.2 Sigma-Aldrich Business Overview
  • 11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
  • 11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2015-2020)
  • 11.10.5 Sigma-Aldrich Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer